93 related articles for article (PubMed ID: 10219254)
1. Hematopoietic deficiencies and core binding factor expression in murine Ts16, an animal model for Down syndrome.
Gjertson C; Sturm KS; Berger CN
Clin Immunol; 1999 Apr; 91(1):50-60. PubMed ID: 10219254
[TBL] [Abstract][Full Text] [Related]
2. Core-binding factor: a central player in hematopoiesis and leukemia.
Speck NA; Stacy T; Wang Q; North T; Gu TL; Miller J; Binder M; Marín-Padilla M
Cancer Res; 1999 Apr; 59(7 Suppl):1789s-1793s. PubMed ID: 10197598
[TBL] [Abstract][Full Text] [Related]
3. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
Wechsler J; Greene M; McDevitt MA; Anastasi J; Karp JE; Le Beau MM; Crispino JD
Nat Genet; 2002 Sep; 32(1):148-52. PubMed ID: 12172547
[TBL] [Abstract][Full Text] [Related]
4. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice.
Sumarsono SH; Wilson TJ; Tymms MJ; Venter DJ; Corrick CM; Kola R; Lahoud MH; Papas TS; Seth A; Kola I
Nature; 1996 Feb; 379(6565):534-7. PubMed ID: 8596630
[TBL] [Abstract][Full Text] [Related]
5. Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice.
Yanagida M; Osato M; Yamashita N; Liqun H; Jacob B; Wu F; Cao X; Nakamura T; Yokomizo T; Takahashi S; Yamamoto M; Shigesada K; Ito Y
Oncogene; 2005 Jun; 24(28):4477-85. PubMed ID: 15856017
[TBL] [Abstract][Full Text] [Related]
6. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.
Ichikawa M; Asai T; Saito T; Seo S; Yamazaki I; Yamagata T; Mitani K; Chiba S; Ogawa S; Kurokawa M; Hirai H
Nat Med; 2004 Mar; 10(3):299-304. PubMed ID: 14966519
[TBL] [Abstract][Full Text] [Related]
7. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
Schuringa JJ; Wu K; Morrone G; Moore MA
Stem Cells; 2004; 22(7):1191-204. PubMed ID: 15579639
[TBL] [Abstract][Full Text] [Related]
8. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia.
Song WJ; Sullivan MG; Legare RD; Hutchings S; Tan X; Kufrin D; Ratajczak J; Resende IC; Haworth C; Hock R; Loh M; Felix C; Roy DC; Busque L; Kurnit D; Willman C; Gewirtz AM; Speck NA; Bushweller JH; Li FP; Gardiner K; Poncz M; Maris JM; Gilliland DG
Nat Genet; 1999 Oct; 23(2):166-75. PubMed ID: 10508512
[TBL] [Abstract][Full Text] [Related]
9. Identification and expression of a novel 3'-exon of mouse Runx1/Pebp2alphaB/Cbfa2/AML1 gene.
Tsuji K; Noda M
Biochem Biophys Res Commun; 2000 Jul; 274(1):171-6. PubMed ID: 10903914
[TBL] [Abstract][Full Text] [Related]
10. lyl-1 and tal-1/scl, two genes encoding closely related bHLH transcription factors, display highly overlapping expression patterns during cardiovascular and hematopoietic ontogeny.
Giroux S; Kaushik AL; Capron C; Jalil A; Kelaidi C; Sablitzky F; Dumenil D; Albagli O; Godin I
Gene Expr Patterns; 2007 Jan; 7(3):215-26. PubMed ID: 17112790
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis.
Wang Q; Stacy T; Binder M; Marin-Padilla M; Sharpe AH; Speck NA
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3444-9. PubMed ID: 8622955
[TBL] [Abstract][Full Text] [Related]
12. Altered astrocyte calcium homeostasis and proliferation in theTs65Dn mouse, a model of Down syndrome.
Bambrick LL; Yarowsky PJ; Krueger BK
J Neurosci Res; 2003 Jul; 73(1):89-94. PubMed ID: 12815712
[TBL] [Abstract][Full Text] [Related]
13. The AML1 transcription factor functions to develop and maintain hematogenic precursor cells in the embryonic aorta-gonad-mesonephros region.
Mukouyama Y; Chiba N; Hara T; Okada H; Ito Y; Kanamaru R; Miyajima A; Satake M; Watanabe T
Dev Biol; 2000 Apr; 220(1):27-36. PubMed ID: 10720428
[TBL] [Abstract][Full Text] [Related]
14. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
15. A fine structural study of the hippocampus and dorsal root ganglion in mouse trisomy 16, a model of Down's syndrome.
Lane NJ; Balbo A; Rapoport SI
Cell Biol Int; 1996 Oct; 20(10):673-80. PubMed ID: 8969460
[TBL] [Abstract][Full Text] [Related]
16. [Regulation of hematopoiesis by transcription factors].
Kurokawa M; Hirai H
Tanpakushitsu Kakusan Koso; 2000 Jun; 45(9 Suppl):1565-72. PubMed ID: 10879135
[No Abstract] [Full Text] [Related]
17. Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development.
Fujita Y; Nishimura M; Taniwaki M; Abe T; Okuda T
Biochem Biophys Res Commun; 2001 Mar; 281(5):1248-55. PubMed ID: 11243869
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen intermediates during programmed cell death induced in the thymus of the Ts(1716)65Dn mouse, a murine model for human Down's syndrome.
Paz-Miguel JE; Flores R; Sánchez-Velasco P; Ocejo-Vinyals G; Escribano de Diego J; López de Rego J; Leyva-Cobián F
J Immunol; 1999 Nov; 163(10):5399-410. PubMed ID: 10553065
[TBL] [Abstract][Full Text] [Related]
19. RUNX1 DNA-binding mutants, associated with minimally differentiated acute myelogenous leukemia, disrupt myeloid differentiation.
Cammenga J; Niebuhr B; Horn S; Bergholz U; Putz G; Buchholz F; Löhler J; Stocking C
Cancer Res; 2007 Jan; 67(2):537-45. PubMed ID: 17234761
[TBL] [Abstract][Full Text] [Related]
20. Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.
Fliegauf M; Stock M; Berg T; Lübbert M
Oncogene; 2004 Dec; 23(56):9070-81. PubMed ID: 15489901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
